American Journal of Clinical Dermatology

, Volume 3, Issue 6, pp 371–380 | Cite as

Epidermolysis Bullosa

New and Emerging Trends
Leading Article

Abstract

Epidermolysis bullosa is a family of inherited blistering skin disorders characterized by blister formation in response to mechanical trauma. Major types of epidermolysis bullosa include epidermolysis bullosa simplex, hemidesmosomal epidermolysis bullosa, junctional epidermolysis bullosa, and dystrophic epidermolysis bullosa.

Current treatment for epidermolysis bullosa consists of supportive care for skin and other organ systems and entails a combination of wound management, infection support for chronic wounds, surgical management as needed, nutritional support, and preventative screening for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. The regimen must be tailored specifically to the severity and extent of skin and systemic involvement in each case.

Recent studies have identified specific protein and genetic abnormalities for most epidermolysis bullosa subtypes. These new advancements in the understanding of molecular pathophysiology have provided much of the basis for current efforts to develop effective gene and protein therapy for epidermolysis bullosa.

Notes

Acknowledgments

The authors would like to gratefully acknowledge the assistance of Eric Lin and Nancy Griffiths in the preparation of this manuscript, the funding assistance of the Palo Alto VA Health Care System and NIH grants P01-44102 and R01-AR47223, and the support and encouragement of the Epidermolysis Bullosa Medical Research Foundation.

References

  1. 1.
    Burgeson R.E., Christiano A.M. The dermal-epidermal junction. Curr Opin Cell Biol 1997; 9 (5): 651–658PubMedCrossRefGoogle Scholar
  2. 2.
    Marinkovich M.P. The molecular genetics of basement membrane diseases. Arch Dermatol 1993; 129: 1557–1565PubMedCrossRefGoogle Scholar
  3. 3.
    Fuchs E., Green H. The expression of keratin genes in epidermis and cultured epidermal cells. Cell 1978; 15 (3): 887–897PubMedCrossRefGoogle Scholar
  4. 4.
    Heida Y., Nishizawa Y., Uematsu J., et al. Identification of a new major hemidesmosomal protein, HD1: a major high molecular mass component of isolated hemidesmosomes. J Cell Biol 1992; 116: 1497–1506CrossRefGoogle Scholar
  5. 5.
    Liu J.G., Mayne R. The complete cDNA coding sequence and tissue-specific expression of the mouse laminin alpha4 chain. Matrix Biol 1996; 15 (6): 433–437PubMedCrossRefGoogle Scholar
  6. 6.
    Sawamura D.K., Li K., Chu M.L., et al. Human bullous pemphigoid antigen (BPAG1): amino acid sequence deduced from cloned cDNAs predicts biologically important peptide segments and protein domains. J Biol Chem 1991; 266: 17784–17790PubMedGoogle Scholar
  7. 7.
    Rezniczek G.A., de Pereda J.M., Reipert S., et al. Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites. J Cell Biol 1998; 141 (1): 209–225PubMedCrossRefGoogle Scholar
  8. 8.
    Borradori L., Chavanas S., Schaapveld R.Q., et al. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion: reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes. Exp Cell Res 1998; 239 (2): 463–476PubMedCrossRefGoogle Scholar
  9. 9.
    Rousselle P., Lunstrum G.P., Keene D.R., et al. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 1991; 114: 567–576PubMedCrossRefGoogle Scholar
  10. 10.
    Marinkovich M.P., Lunstrum G.P., Burgeson R.E. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992; 267: 17900–17906PubMedGoogle Scholar
  11. 11.
    Marinkovich M.P., Lunstrum G.P., Keene D.R., et al. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 1992; 119: 695–703PubMedCrossRefGoogle Scholar
  12. 12.
    Giudice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992; 99 (3): 243–250PubMedCrossRefGoogle Scholar
  13. 13.
    Sonnenberg A., Calafat J., Janssen H., et al. Integrin a6b4 complex is located in hemidesomosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991; 113: 907–917PubMedCrossRefGoogle Scholar
  14. 14.
    Champliaud M.F., Lunstrum G.P., Rousselle P., et al. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 1996; 132 (6): 1189–1198PubMedCrossRefGoogle Scholar
  15. 15.
    Niessen C.M., Hogervorst F., Jaspars L.H., et al. The a6 b4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211: 360–367PubMedCrossRefGoogle Scholar
  16. 16.
    Burgeson R.E., Lundstrum G.P., Rokosova B. The structure and function of type VII collagen. Ann NY Acad Sci 1990; (580): 32–43PubMedCrossRefGoogle Scholar
  17. 17.
    Rousselle P., Keene D.R., Ruggiero F., et al. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol 1997; 138 (3): 719–728PubMedCrossRefGoogle Scholar
  18. 18.
    Fine J.D., Eady R.A., Bauer E.A., et al. Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000; 42 (6): 1051–1066PubMedCrossRefGoogle Scholar
  19. 19.
    Uitto J., Pulkkinen L., McLean W.H. Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity. Mol Med Today 1997; 3 (10): 457–465PubMedCrossRefGoogle Scholar
  20. 20.
    Bruckner-Tuderman L., Höpfner B., Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 1999; 18 (1): 43–54PubMedCrossRefGoogle Scholar
  21. 21.
    Marinkovich M.P., Herron G.S., Khavari P.A., et al. Inherited epidermolysis bullosa. In: Freedberg I.M., editor. Dermatology in general medicine. New York: MacGraw-Hill, 1999: 690–702Google Scholar
  22. 22.
    Bonidas J.M., Rothman A.L., Spstein E.H. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991; 254: 1202–1205CrossRefGoogle Scholar
  23. 23.
    Coulombe P.A., Hutton M.E., Letai A., et al. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyzes. Cell 1991; 66: 1301–1311PubMedCrossRefGoogle Scholar
  24. 24.
    Hovnanian A., Duquesnoy P., Amselem S. Genetic linkage of recessive epidermolysis bullosa to the type VII collagen gene. J Clin Invest 1992; (90): 1033–1037CrossRefGoogle Scholar
  25. 25.
    Jonkman M.F., Herres K., Pas H.H., et al. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 1996; 107 (5): 764–769PubMedCrossRefGoogle Scholar
  26. 26.
    Koebner H. Hereditare Anlage zur Blasenbildung. Dtsch Med Wochenschr 1886; 12: 21CrossRefGoogle Scholar
  27. 27.
    Weber F.P. Recurrent bullous eruption on the feet in a child. Proc R Soc Med 1926; 19: 72PubMedGoogle Scholar
  28. 28.
    Meneguzzi G., Marinkovich M.P., Aberdan D., et al. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz’s junctional epidermolysis bullosa patients. Exp Dermatol 1992; 1 (5): 221–229PubMedCrossRefGoogle Scholar
  29. 29.
    Jonkman M.F., de Jong M.C.J.M., Heeres K., et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 1995; 95 (3): 1345–1352PubMedCrossRefGoogle Scholar
  30. 30.
    Aberdam D., Galliano M.F., Vailly J., et al. Herlitz’s junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the g2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 1994; 6 (3): 299–304PubMedCrossRefGoogle Scholar
  31. 31.
    Pulkkinen L., Christiano A.M., Gerecke D., et al. A homozygous nonsense mutation in the ß 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994; 24 (2): 357–360PubMedCrossRefGoogle Scholar
  32. ai]32.
    Pulkkinen L., Christiano A.M., Airenne T., et al. Mutations in the g2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 1994; 6: 293–298PubMedCrossRefGoogle Scholar
  33. 33.
    Kivirikko S., McGrath J.A., Pulkkinen L., et al. Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. Hum Mol Genet 1996; 5 (2): 231–237PubMedCrossRefGoogle Scholar
  34. 34.
    Marinkovich M.P., Verrando P., Keene D.R., et al. The basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab Invest 1993; 69: 295–299PubMedGoogle Scholar
  35. 35.
    Hashimoto I., Schnyder U.W., Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica 1976; 152 (2): 72–86PubMedCrossRefGoogle Scholar
  36. 36.
    Hintner H., Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982; 118 (6): 375–384PubMedCrossRefGoogle Scholar
  37. 37.
    Uitto J., Pulkkinen L., Christiano A.M. Molecular basis of the dystrophic and junctional form of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin-5) genes. J Invest Dermatol 1994; 103 (5 Suppl.): S39–S46CrossRefGoogle Scholar
  38. 38.
    Parente M.G., Chung L.C., Fyynanen J., et al. Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A 1991; 88 (16): 6931–6935PubMedCrossRefGoogle Scholar
  39. 39.
    McGrath J.A., Schofield D.M., Mayou B.J., et al. Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J Cutan Pathol 1992; 19 (2): 116–123PubMedCrossRefGoogle Scholar
  40. 40.
    Smith L.T. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol 1993; 129 (12): 1578–1584PubMedCrossRefGoogle Scholar
  41. 41.
    Marinkovich M.P. Update on inherited bullous dermatoses. Dermatol Clin 1999; 17 (3): 473–485PubMedCrossRefGoogle Scholar
  42. 42.
    McLean W.H., Pulkkinen L., Smith P.J., et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 1996; 10 (14): 1724–1735PubMedCrossRefGoogle Scholar
  43. 43.
    Chavanas S., Pulkkinen L., Gache Y., et al. A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest 1996; 98 (10): 2196–2200PubMedCrossRefGoogle Scholar
  44. 44.
    Elliott C.E., Becker B., Oehler S., et al. Plectin transcript diversity: identification and tissue distribution of variants with distinct first coding exons and rodless isoforms. Genomics 1997; 42 (1): 115–125PubMedCrossRefGoogle Scholar
  45. 45.
    Ruzzi L., Gagnoux-Palacios L., Pinola M., et al. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest 1997; 99 (12): 2826–2831PubMedCrossRefGoogle Scholar
  46. 46.
    Vidal F., Aberdam D., Miquel C., et al. Integrin ß 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 1995; 10 (2): 229–234PubMedCrossRefGoogle Scholar
  47. 47.
    Zimmer K.P., Schumann H., Mecklenbeck S., et al. Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations. Gastroenterology 2002; 122 (1): 220–225PubMedCrossRefGoogle Scholar
  48. 48.
    Pulkkinen L., Rouan F., Bruckner-Tuderman L., et al. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet 1998; 63 (5): 1376–1387PubMedCrossRefGoogle Scholar
  49. 49.
    Nakano A., Pulkkinen L., Murrell D., et al. Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the ß 4 integrin gene (ITGB4) and genotype/ phenotype correlations. Pediatr Res 2001; 49 (5): 618–626PubMedCrossRefGoogle Scholar
  50. 50.
    Tidman M.J., Eady R.A.J. Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis. J Invest Dermatol 1986; (86): 51–56PubMedCrossRefGoogle Scholar
  51. 51.
    Tidman M.J., Eady R.A.J. Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol 1985; (84): 374–377PubMedCrossRefGoogle Scholar
  52. 52.
    Pearson R.W. Histopathologic and ultrastructional findings in certain genodermatoses. Clin Dermatol 1985; (3): 143–174PubMedCrossRefGoogle Scholar
  53. 53.
    Lin AN, Carter DM, editors. Epidermolysis bullosa: basic and clinical aspects. New York: Springer-Verlag, 1992: 302Google Scholar
  54. 54.
    Carter D.M., Lin A.N., Varghese M.C., et al. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol 1987; 17 (2 Pt 1): 246–250PubMedCrossRefGoogle Scholar
  55. 55.
    Hill J.C., Grimwood R.E., Parsons D.S. Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts. J Dermatol Surg Oncol 1992; 18 (5): 396–400PubMedGoogle Scholar
  56. 56.
    Bastin K.T., Steeves R.A., Richards M.J. Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis: case reports and literature review. Am J Clin Oncol 1997; 20 (1): 55–58PubMedCrossRefGoogle Scholar
  57. 57.
    Ladd A.L., Kibele A., Gibbons S. Surgical treatment and postoperative splinting of recessive dystrophic epidermolysis bullosa. J Hand Surg [Br] 1996; 21 (5): 888–897Google Scholar
  58. 58.
    Terrill P.J., Mayou B.J., Pemberton J. Experience in the surgical management of the hand in dystrophic epidermolysis bullosa. Br J Plast Surg 1992; 45 (6): 435–442PubMedCrossRefGoogle Scholar
  59. 59.
    Vozdvizhensky S.I., Albanova V.I. Surgical treatment of contracture and syndactyly of children with epidermolysis bullosa. Br J Plast Surg 1993; 46 (4): 314–316PubMedCrossRefGoogle Scholar
  60. 60.
    Terrill P.J., Mayou B.J., McKee P.H., et al. The surgical management of dystrophic epidermolysis bullosa (excluding the hand). Br J Plast Surg 1992; 45 (6): 426–434PubMedCrossRefGoogle Scholar
  61. 61.
    Travis S.P., McGrath J.A., Turnbull A.J., et al. Oral and gastrointestinal manifestations of epidermolysis bullosa. Lancet 1992; 340: 1505–1506PubMedCrossRefGoogle Scholar
  62. 62.
    Griffin R.P., Mayou B.J. The anesthetic management of patients with dystrophic epidermolysis bullosa: a review of 44 patients over a 10 year period. Anesthesia 1993; 48 (9): 810–815CrossRefGoogle Scholar
  63. 63.
    Shah M.D., Berman W.F. Endoscopic balloon dilation of esophageal strictures in children. Gastrointest Endosc 1993; 39 (2): 153–156PubMedCrossRefGoogle Scholar
  64. 64.
    Haynes L., Atherton D.J., Ade-Ajayi N., et al. Gastrostomy and growth in dystrophic epidermolysis bullosa. Br J Dermatol 1996; 134 (5): 872–879PubMedCrossRefGoogle Scholar
  65. 65.
    Haynes L., Atherton D., Clayden G. Constipation in epidermolysis bullosa: successful treatment with a liquid fiber-containing formula. Pediatr Dermatol 1997; 14 (5): 393–396PubMedCrossRefGoogle Scholar
  66. 66.
    Lin A.N., Murphy F., Brodie S.E., et al. Review of ophthalmic findings in 204 patients with epidermolysis bullosa. Am J Ophthalmol 1994; 118 (3): 384–390PubMedGoogle Scholar
  67. 67.
    Tong L., Hodgkins P.R., Denyer J., et al. The eye in epidermolysis bullosa. Br J Ophthalmol 1999; 83 (3): 323–326PubMedCrossRefGoogle Scholar
  68. 68.
    Wright J.T., Fine F.D., Johnson L. Dental carries risk of hereditary epidermolysis bullosa. Pediatr Dent 1994; 16 (6): 427–432PubMedGoogle Scholar
  69. 69.
    Lechner-Gruskay D., Honig P.J., Pereira G., et al. Nutritional and metabolic profile of children with epidermolysis bullosa. Pediatr Dermatol 1988; 5 (1): 22–27PubMedCrossRefGoogle Scholar
  70. 70.
    Birge K. Nutrition management of patients with epidermolysis bullosa. J Am Diet Assoc 1995; 95 (5): 575–579PubMedCrossRefGoogle Scholar
  71. 71.
    Darling T.N., Bauer J.W., Hintner H., et al. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 1997; 13: 87–119PubMedGoogle Scholar
  72. 72.
    Fridge J.L., Vichinsky E.P. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr 1998; 132 (5): 871–873PubMedCrossRefGoogle Scholar
  73. 73.
    Atherton D.J., Cox I., Hann I. Intravenous iron (III) hydroxide-sucrose complex for anemia in epidermolysis bullosa [letter]. Br J Dermatol 1999; 140 (4): 773PubMedGoogle Scholar
  74. 74.
    Caldwell-Brown D., Stern R.S., Lin A.N., et al. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa: Epidermolysis Bullosa Study Group. N Engl J Med 1992; 327 (3): 163–167PubMedCrossRefGoogle Scholar
  75. 75.
    Unger W.P., Nethercott J.R. Epidermolysis bullosa dystrophica treated with vitamin E and oral corticosteroids. Can Med Assoc J 1973; 108 (9): 1136–1138PubMedGoogle Scholar
  76. 76.
    Smith E.B., Michener W.M. Vitamin E treatment of dermolytic bullous dermatosis: a controlled study. Arch Dermatol 1973; 108 (2): 254–256PubMedCrossRefGoogle Scholar
  77. 77.
    Shirakata Y., Shiraishi S., Sayama K., et al. High-dose tocopherol acetate therapy in epidermolysis bullosa siblings of the Cockayne-Touraine type. J Dermatol 1993; 20 (11): 723–725PubMedGoogle Scholar
  78. 78.
    Fritsch P., Klein G., Aubock J., et al. Retinoid therapy of recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 1983; 9 (5): 766–767PubMedCrossRefGoogle Scholar
  79. 79.
    Andreano J.M., Tomecki J.K. Epidermolysis bullosa simplex responding to isotretinoin. Arch Dermatol 1988; 124 (9): 1445–1446PubMedCrossRefGoogle Scholar
  80. 80.
    Husz S., Olah J., Korom I., et al. Cyclosporin for dystrophic epidermolysis bullosa. Lancet 1989; II (8676): 1393–1394CrossRefGoogle Scholar
  81. 81.
    Coberly S.B.M., Tran H.T., Keene D.R., et al. Exogenous laminin 5 protein therapy corrects JEB keratinocyte adhesive defects in vitro and basement membrane defects in a JEB skin equivalent system [abstract]. J Invest Dermatol 1997; 108: 549AGoogle Scholar
  82. 82.
    Khavari P.A. Genetic correction of inherited epidermal disorders. Hum Gene Ther 2000; 11 (16): 2277–2282PubMedCrossRefGoogle Scholar
  83. 83.
    Dellambra E., Vailly J., Pellegrini G., et al. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther 1998; 9 (9): 1359–1370PubMedCrossRefGoogle Scholar
  84. 84.
    Robbins P.B., Lin Q., Goodnough J., et al. In vivo restoration of laminin 5 ß 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A 2001; 98 (9): 5193–5198PubMedCrossRefGoogle Scholar
  85. 85.
    Dellambra E., Prislei S., Salvati A.L., et al. Gene correction of integrin ß 4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for ß 4 tyrosines 1422 and 1440 in hemidesmosome assembly. J Biol Chem 2001; 276 (44): 41336–41342PubMedCrossRefGoogle Scholar
  86. 86.
    Blau H., Khavari P. Gene therapy: progress, problems, prospects. Nat Med 1997; 3 (6): 612–613PubMedCrossRefGoogle Scholar
  87. 87.
    Santana E., Peritz A.E., Iyer S., et al. Different frequency of gene targeting events by the RNA-DNA oligonucleotide among epithelial cells. J Invest Dermatol 1998; 111 (6): 1172–1177PubMedCrossRefGoogle Scholar
  88. 88.
    Lin M.T., Pulkkinen L., Uitto J., et al. The gene gun: current applications in cutaneous gene therapy. Int J Dermatol 2000; 39 (3): 161–170PubMedCrossRefGoogle Scholar
  89. 89.
    Lin M.T., Wang F., Uitto J., et al. Differential expression of tissue-specific promoters by gene gun. Br J Dermatol 2001; 144 (1): 34–39PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  1. 1.Department of DermatologyStanford University School of MedicineStanfordUSA
  2. 2.Palo Alto VA Medical CenterPalo AltoUSA

Personalised recommendations